Identification of chicken-derived antibodies targeting the Candida albicans Als3 protein
Applied Microbiology and Biotechnology · 08.04.2025 · 109 (1)
DOI: 10.1007/s00253-025-13469-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 08.04.2025. Verfasst von Chi-Hsin Lee und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, No. 301, Yuantong Rd., …. Hauptthemen laut MEDLINE: Single-Chain Antibodies, Antibodies, Fungal, Candida albicans, Fungal Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council.
Abstract (Originalsprache)
Candida albicans is a major opportunistic pathogen, responsible for nearly half of clinical candidemia cases. The rising prevalence of azole-resistant Candida species represents a significant clinical challenge, underscoring the urgent need for alternative therapeutic strategies. Monoclonal antibody-based therapies have emerged as a promising and cost-effective approach to combating Candida infections. Agglutinin-like sequence protein 3 (Als3), a key cell surface protein of C. albicans , plays a pivotal role in adherence and biofilm formation, both of which are essential for its pathogenesis. In this study, recombinant Als3 protein was purified and utilized to immunize chickens, resulting in the production of Als3-specific immunoglobulin Y (IgY) antibodies. Two single-chain variable fragment (scFv) antibody libraries were subsequently constructed using phage display technology, yielding transformant counts of 5.3 × 10 7 and 2.8 × 10 7 , respectively. Phage-based enzyme-linked immunosorbent assay (ELISA) revealed enhanced signals following bio-panning, enabling the identification and sequence validation of three scFv antibodies. These scFv antibodies exhibited strong binding activities to Als3, as confirmed through ELISA and western blot analyses. Binding affinities were determined to be ~ 10⁻⁸ M via serial titration ELISA and competitive ELISA. Additionally, the selected scFv antibodies specifically recognized endogenous Als3 protein in C. albicans , as demonstrated by western blot and cell-based ELISA assays. In conclusion, this study successfully generated and characterized high-affinity scFv antibodies targeting Als3, which exhibited exceptional specificity and binding activity. These findings highlight their potential as promising immunotherapeutic candidates for the treatment of C. albicans infections. Key points • The Als3 protein of C. albicans is a critical biomarker and therapeutic target • Chicken-derived scFv antibodies against Als3 were developed via phage display • The scFv antibodies showed strong binding to endogenous Als3 in C. albicans
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, No. 301, Yuantong Rd., Zhonghe Dist., New Taipei City, 235, Taiwan.
- Ph.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University Inc., Taipei, 110301, Taiwan.
- Core Laboratory of Antibody Generation and Research, Taipei Medical University, Taipei, 110301, Taiwan.
- Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 110301, Taiwan.
- Institute of Biotechnology, National Tsing Hua University, Hsinchu, 300044, Taiwan.
- National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, 350401, Taiwan.
Förderung
- National Science and Technology Council
Zitieren
APA
Lee, C. H., Wu, C. J., Yen, F. Y., Chiang, J. Y., Shen, T. J., Leu, S. J., Chang, C. R., Lo, H. J., Tsai, B. Y., Mao, Y. C., Andriani, V., Thenaka, P. C., Wang, W. C., Chao, Y. P., & Yang, Y. Y. (2025). Identification of chicken-derived antibodies targeting the Candida albicans Als3 protein. Applied Microbiology and Biotechnology, 109(1). https://doi.org/10.1007/s00253-025-13469-3
Vancouver
Lee CH, Wu CJ, Yen FY, Chiang JY, Shen TJ, Leu SJ, et al. Identification of chicken-derived antibodies targeting the Candida albicans Als3 protein. Applied Microbiology and Biotechnology. 2025;109(1). doi:10.1007/s00253-025-13469-3
BibTeX
@article{Lee2025,
author = {Lee, Chi-Hsin and Wu, Chao-Jung and Yen, Fang-Yi and Chiang, Jia-Yun and Shen, Ting-Jing and Leu, Sy-Jye and Chang, Chuang-Rung and Lo, Hsiu-Jung and Tsai, Bor-Yu and Mao, Yan-Chiao and Andriani, Valencia and Thenaka, Priskila Cherisca and Wang, Wei-Chu and Chao, Yu-Pin and Yang, Yi-Yuan},
title = {Identification of chicken-derived antibodies targeting the Candida albicans Als3 protein},
journal = {Applied Microbiology and Biotechnology},
year = {2025},
volume = {109},
number = {1},
doi = {10.1007/s00253-025-13469-3}
}
EUVIMED